Mutations of p53 gene exons 4-8 in human esophageal cancer

World Journal of Gastroenterology

Volumn 11, Issue 19, 2005, Pages 2998-3001

  Li, Li Ya ^a   Tang, Jin Tian ^b   Jia, Li Qun ^a   Li, Pei Wen ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Esophageal cancer; Gene p53

Indexed keywords

PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CANCER; EXON; FEMALE; GENDER; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PREOPERATIVE CARE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR LOCALIZATION;

EID: 20344389506     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i19.2998     Document Type: Article

References (25)

1. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monoer 1982; 62: 113-120
2. Finlay CA, Hinds PW, Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991; 253: 49-53
4. Vos M, Adams CH, Victor TC, van Helden PD. Polymorphisms and mutations found in the regions flanking exon 5 to 8 of the TP53 gene in a poalation at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 2003; 140: 23-30
5. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51(23 Pt 1): 6304-6311
6. Lane DP. P53, guardian of the genome. Nature 1992; 358: 15-16
7. Oren M. Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 1994; 5: 221-225
8. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P. Mutation in the p53 gene occurs in diverse human tumor types. Nature 1989; 342: 705-708
9. Alidina A, Siddiqui T, Burney I, Jafri W, Hussain F, Ahmed M. Esophageal Cancer-a review. J Pak Med Assoc 2004; 54: 136-141
10. Gamliel Z. Incidence, epidemiology and etiology of esophageal cancer. Chest Surg Clin N Am 2000; 10: 441-450
11. Blot WJ, Devessa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289
12. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patters in the incidence of esophageal and gastric carcinoma in the united states. Cancer 1998; 83: 2049-2053
13. Heitmiller RF, Sharma RR. Comparison of incidence and resection rates in patients with esophageal squamons cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996; 112: 130-136
14. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54: 4342-4346
15. Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, Xing EP, Yang CS. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20: 591-597
16. Fujiki T, Haraoka S, Yoshioka S, Ohshima K, Iwashita A, Kikuchi M. p53 gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma. Int J Oncol 2002; 20: 669-679
17. Putz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, Klug SJ, Rabes HM. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int J Cancer 2002; 98: 99-105
18. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene 2001; 20: 7368-7374
19. Kihara C, Seki T, Furukawa Y, Yamana H, Kimura Y, van Schaardenburgh P, Hirata K, Nakamura Y. Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients. Jpn J Cancer Res 2000; 91: 190-198
20. Wang LS, Chow KC, Liu CC, Chiu JH. P53 gene alternation in squamius cell carcinoma of the esophagus detected by PCR-cold SSCP analysis. Proc Natl Sci Counc Repub China B 1998; 22: 114-121
21. Ireland AP, Clark GW, DeMeester TR. Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg 1997; 225: 17-30
22. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
23. Mitra G, Pauly GT, Kumar R, Pei GK, Hughes SH, Moschel RC, Barbacid M. Molecular analysis of O6-substituted guanine-induced mutagens ras oncogenes. Proc Natl Acad Sci USA 1989; 86: 8650-8654
24. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996; 69: 225-235
25. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni JF Jr, Pace JM. Mutation of the K-ras and p53 genes in gastric adenocarcinoma from a high-incidence region around florence, Italy. Cancer Res 1995; 55: 2665-2672